Further support of our findings is coming from data from the Human Protein Atlas where a trend for a better survival probability for ovarian cancer patients is associated with higher OATP5A1 mRNA expression levels (https://www.proteinatlas.org/ENSG00000137571-SLCO5A1/pathology). This evidence concerns the gene SLCO5A1 and ovarian carcinoma.